Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk"
Autoantibody Positive Non-diabetic Relatives at Risk for Type 1 Diabetes High Risk Impaired Glucose Tolerance type 1 diabetes pre-diabetic at risk for type 1 diabetes glucose intolerance relatives of people with type 1 diabetes Diabetes Mellitus Diabetes Mellitus, Type 1 Teplizumab
Lead Scientist at UCSF
- Stephen Gitelman
I am involved in a variety of different translational and clinical research projects, most related to diabetes. A number of the on-going studies are attempts to alter the course of autoimmune-mediated type 1 diabetes, often via immunomodulation, in order to preserve endogenous beta cell function. Some of the recent and on-going projects are described below.